Enter the first few characters of Company and click 'Go'
Audited Results of GlaxoSmithKline Pharmaceuticals Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
3,216.34 |
3,217.51 |
2,920.48 |
3,224.68 |
3,128.53 |
Manufacturing Expenses |
103.44 |
121.30 |
108.04 |
33.36 |
27.94 |
Personnel Expenses |
594.99 |
610.23 |
616.16 |
628.55 |
537.20 |
Selling Expenses |
0 |
0 |
0 |
138.23 |
0 |
Administrative Expenses |
462.50 |
429.76 |
346.03 |
457.13 |
595.15 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
2,416.92 |
2,461.68 |
2,322.70 |
2,566.23 |
2,522.05 |
Operating Profit |
799.43 |
755.83 |
597.77 |
658.45 |
606.48 |
Other Recurring Income |
101.51 |
76.22 |
110.19 |
77.56 |
101.48 |
Adjusted PBDIT |
900.94 |
832.04 |
707.96 |
736.01 |
707.96 |
Financial Expenses |
1.81 |
1.99 |
3.53 |
6.34 |
0.55 |
Depreciation |
65.77 |
68.19 |
78.60 |
82.68 |
48.59 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
833.36 |
761.87 |
625.83 |
646.99 |
658.82 |
Tax Charges |
227.69 |
396.87 |
166.54 |
212.45 |
238.35 |
Adjusted PAT |
605.67 |
365 |
459.29 |
434.55 |
420.47 |
Non Recurring Items |
2.08 |
1,325.53 |
-101.72 |
-324.49 |
4.89 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
607.75 |
1,690.53 |
357.57 |
110.05 |
425.36 |
Equity Dividend |
1,524.66 |
508.22 |
677.62 |
269.17 |
235.52 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
828.12 |
1,745.02 |
562.71 |
952.41 |
1,242.11 |